Santen Pharmaceutical Co., Ltd. Stock Deutsche Boerse AG
Stocks
SZD
JP3336000009
Pharmaceuticals
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.60 EUR | +2.91% |
|
-2.80% | +19.54% |
| Market Cap | 631B 3.85B 3.39B 3.15B 2.89B 5.43B 373B 5.53B 37.64B 14.68B 182B 14.46B 14.15B | P/E 2027 * |
16x | P/E 2028 * | 15.2x |
|---|---|---|---|---|---|
| Enterprise Value | 584B 3.56B 3.13B 2.91B 2.68B 5.02B 345B 5.11B 34.82B 13.58B 168B 13.38B 13.09B | EV / Sales 2027 * |
1.93x | EV / Sales 2028 * | 1.78x |
| Free-Float |
96.71% | Yield 2027 * |
2.12% | Yield 2028 * | 2.4% |
| 23-09-29 | ETF der Woche: Back to the Roots | |
| 23-09-28 | ETF van de week: terug naar de basis | |
| 23-09-28 | L'ETF della settimana: ritorno ai fondamentali | |
| 23-09-28 | ETF de la semaine : Retour aux fondamentaux | |
| 21-02-15 | Nicox S A : A suivre aujourd'hui |
| 1 day | +2.91% | ||
| 1 week | -2.80% | ||
| Current month | -8.77% | ||
| 1 month | -5.45% | ||
| 3 months | +18.86% | ||
| 6 months | +11.83% | ||
| Current year | +19.54% |
| 1 week | 10.3 |  | 11 |
| 1 month | 10.3 | | 11.9 |
| Current year | 8.3 | | 11.9 |
| 1 year | 8.05 | | 11.9 |
| 3 years | 7.5 | | 11.9 |
| 5 years | 6.4 | | 13.5 |
| 10 years | 6.4 | | 18.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Takeshi Ito
CEO | Chief Executive Officer | 67 | 2022-08-31 |
Kazuo Koshiji
DFI | Director of Finance/CFO | - | - |
Peter Salstig
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Takeshi Ito
BRD | Director/Board Member | 67 | 2017-06-22 |
Ippei Kurihara
BRD | Director/Board Member | 45 | 2024-05-31 |
Rie Nakajima
BRD | Director/Board Member | 48 | 2024-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.91% | -2.80% | - | - | 3.85B | |
| +0.96% | +1.14% | +48.07% | +159.64% | 1,057B | |
| +1.01% | +3.62% | +54.63% | +53.26% | 624B | |
| +0.88% | +1.89% | +35.87% | +81.09% | 454B | |
| +1.52% | +6.31% | +34.02% | +29.91% | 341B | |
| -0.38% | +2.02% | +36.34% | +40.44% | 297B | |
| +0.19% | +1.14% | +16.80% | +18.16% | 262B | |
| +0.67% | -1.70% | -27.46% | -41.04% | 215B | |
| +1.19% | +2.76% | +21.98% | +59.88% | 201B | |
| -0.77% | -2.38% | +15.80% | +68.79% | 162B | |
| Average | +0.84% | +0.77% | +26.23% | +52.24% | 401.55B | |
| Weighted average by Cap. | +0.76% | +1.57% | +35.71% | +77.53% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 303B 1.85B 1.63B 1.51B 1.39B 2.61B 179B 2.65B 18.07B 7.05B 87.35B 6.94B 6.79B | 311B 1.9B 1.67B 1.55B 1.43B 2.68B 184B 2.72B 18.56B 7.24B 89.71B 7.13B 6.98B |
| Net income | 38.51B 235M 207M 192M 177M 331M 22.76B 337M 2.3B 896M 11.1B 882M 863M | 41.13B 251M 221M 205M 189M 354M 24.31B 360M 2.45B 957M 11.86B 942M 922M |
| Net Debt | -47.37B -289M -254M -236M -217M -407M -27.99B -415M -2.82B -1.1B -13.65B -1.09B -1.06B | -76.47B -467M -410M -381M -351M -658M -45.19B -669M -4.56B -1.78B -22.04B -1.75B -1.71B |
| Date | Price | Change |
|---|---|---|
| 26-07-24 | €10.40 | +0.97% |
| 26-07-23 | €10.30 | -1.90% |
| 26-07-22 | €10.50 | -1.87% |
| 26-07-21 | €10.70 | -2.73% |
| 26-07-20 | €11.00 | +2.80% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4536 Stock
- SZD Stock
Select your edition
All financial news and data tailored to specific country editions
